Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04107129 · ClinicalTrials.gov registry record
Predicting Endometrial Receptivity for Optimal Reproductive Management
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 76
- Enrollment target
NCT04107129: Completed study, sponsored by Stanford University.
NCT04107129 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04107129 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
The purpose of this study is to understand why some women are infertile (unable to conceive a child). The investigators hope to learn if an endometrial biopsy after egg retrieval is feasible for detecting biomarkers for endometriosis and predicting implantation and pregnancy rate after embryo transfer. This study design will provide for the first time, an opportunity to compare endometrial biopsy material from hyperstimulated (gonadotropin treated) subjects after egg retrieval. If successful, it would provide a new protocol for women with unexplained infertility or those with known endometriosis to avoid poor IVF outcomes.
Primary Outcome
Endometrial biopsy specimens will be stained for SIRT1 using immunostaining and Hscore assignment.
Interventions
- DIAGNOSTIC_TEST Blood sample
- PROCEDURE Endometrial Biopsy
- OTHER Euploid embryo transfer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2024-07-30 |
What the finished NCT04107129 record still lists
NCT04107129 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Blood sample is the first listed.
NCT04107129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04107129 about?
NCT04107129 is a clinical study titled "Predicting Endometrial Receptivity for Optimal Reproductive Management". The purpose of this study is to understand why some women are infertile (unable to conceive a child). The investigators hope to learn if an endometrial biopsy after egg retrieval is feasible for detecting biomarkers for endometriosis and predicting implantation and pregnancy rate after embryo transf...
What is the current status of trial NCT04107129?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2020-07-01. Estimated completion is 2024-07-30.
What interventions are being tested in trial NCT04107129?
The interventions under investigation include: Blood sample (DIAGNOSTIC_TEST), Endometrial Biopsy (PROCEDURE), Euploid embryo transfer (OTHER).
Who is sponsoring clinical trial NCT04107129?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI